Table 1.
Entry | R | % of BAM15 OCRa | EC50, μM | Entry | R | % of BAM15 OCRa | EC50, μM |
---|---|---|---|---|---|---|---|
BAM15 | 100%b | 0.49 ± 0.06 | 8q | NA | -- | ||
8a | 33%b | 2.3 ± 0.7 | 8r | NA | -- | ||
8b | 22%c | 2.1 ± 1.3 | 8s | NA | -- | ||
8c | 59%c | >20 | 8t | 21%b | 3.9 ± 1.1 | ||
8d | NA | -- | 8u | 18%b | >100 | ||
8e | 43%c | >100 | 8v | 8%b | 2.2 ± 0.4 | ||
8f | 14%c | >100 | 8w | NA | -- | ||
8g | NA | -- | 8x | 5%b | <3 | ||
8h | 45%c | 10.1 ± 0.7 | 8y | 27%b | 8.8 ± 3.2 | ||
8i | NA | -- | 8z | NA | -- | ||
8j | NA | -- | 8aa | 17%b | 1.1 ± 0.4 | ||
8k | NA | -- | 8ab | 7%b | <1 μM | ||
8l | NA | -- | 8ac | NA | -- | ||
8m | 53%c | 1.1 ± 0.2 | 8ad | 0.5%b | <1 μM | ||
8n | 14%c | <5 | 8ae | 1%b | 1.7 ± 0.3 | ||
8o | 39%c | 1.0 ± 0.3 | 8af | 0.3%b | <1 μM | ||
8p | 28%c | 0.7 ± 0.1 | 8ag | 5%b | 6.1 ± 2.6 |
Integrated area under OCR dose curve above baseline relative to that of BAM15 expressed as percent. NA = No Activity.
Highest tested concentration is 200 μM. BAM15 was tested up to 200 μM.
Highest tested concentration is 50 μM. BAM15 was tested up to 50 μM.